These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 2272826)

  • 41. [Enlarged spectrum of tick transmitted spirochaetoses].
    Rufli T; Lehner S; Aeschlimann A; Chamot E; Gigon F; Jeanneret JP
    Hautarzt; 1986 Nov; 37(11):597-602. PubMed ID: 3804731
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Serologic diagnosis of Lyme disease in patients with undifferentiated arthritis. Diagnostic problems].
    Rodríguez-Moreno J; Casanova Rituerto A; Fiter J; Alcaide Fernández de Vega F; Contreras M; Domínguez Luzón MA
    Med Clin (Barc); 1992 Dec; 99(19):732-4. PubMed ID: 1460939
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Serodiagnosis of Lyme borreliosis].
    Wilske B
    Z Hautkr; 1988 Jun; 63(6):511-4. PubMed ID: 3043955
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Course of Borrelia burgdorferi DNA shedding in urine after treatment.
    Aberer E; Bergmann AR; Derler AM; Schmidt B
    Acta Derm Venereol; 2007; 87(1):39-42. PubMed ID: 17225014
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A Dutch nationwide evaluation of serological assays for detection of Borrelia antibodies in clinically well-defined patients.
    Ang CW; Brandenburg AH; van Burgel ND; Bijlmer HA; Herremans T; Stelma F; Lunel FV; van Dam AP;
    Diagn Microbiol Infect Dis; 2015 Nov; 83(3):222-8. PubMed ID: 26286381
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Molecular subtyping of Borrelia burgdorferi in erythema migrans and acrodermatitis chronica atrophicans.
    Wienecke R; Zöchling N; Neubert U; Schlüpen EM; Meurer M; Volkenandt M
    J Invest Dermatol; 1994 Jul; 103(1):19-22. PubMed ID: 8027576
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Current aspects of Lyme disease and other Borrelia burgdorferi infections.
    Berger BW
    Dermatol Clin; 1997 Apr; 15(2):247-55. PubMed ID: 9098634
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Microbiological findings in erythema (chronicum) migrans and related disorders.
    Neubert U; Krampitz HE; Engl H
    Zentralbl Bakteriol Mikrobiol Hyg A; 1986 Dec; 263(1-2):237-52. PubMed ID: 3577483
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The expanding spectrum of cutaneous borreliosis.
    Eisendle K; Zelger B
    G Ital Dermatol Venereol; 2009 Apr; 144(2):157-71. PubMed ID: 19357623
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Borrelia infections from a dermatological viewpoint].
    Vocks E; Engst R; Borelli S
    Monatsschr Kinderheilkd; 1991 Jul; 139(7):425-8. PubMed ID: 1922122
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Improved immunoglobulin M serodiagnosis in Lyme borreliosis by using a mu-capture enzyme-linked immunosorbent assay with biotinylated Borrelia burgdorferi flagella.
    Hansen K; Pii K; Lebech AM
    J Clin Microbiol; 1991 Jan; 29(1):166-73. PubMed ID: 1993753
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Livedo racemosa: an unusual late manifestation of borreliosis?].
    Baumann M; Tebbe B; Arnold M; Krengel S; Goerdt S; Orfanos CE
    Hautarzt; 2000 Aug; 51(8):593-6. PubMed ID: 10997315
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evaluation of in vivo expressed Borrelia burgdorferi antigens for improved IgM serodiagnosis of early Lyme disease.
    Brandt KS; Ullmann AJ; Molins CR; Horiuchi K; Biggerstaff BJ; Gilmore RD
    Diagn Microbiol Infect Dis; 2019 Mar; 93(3):196-202. PubMed ID: 30344068
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Heterogeneity of Borrelia burgdorferi in the skin.
    Aberer E; Kersten A; Klade H; Poitschek C; Jurecka W
    Am J Dermatopathol; 1996 Dec; 18(6):571-9. PubMed ID: 8989928
    [TBL] [Abstract][Full Text] [Related]  

  • 55. No evidence for Borrelia burgdorferi-specific DNA in lesions of localized scleroderma.
    Wienecke R; Schlüpen EM; Zöchling N; Neubert U; Meurer M; Volkenandt M
    J Invest Dermatol; 1995 Jan; 104(1):23-6. PubMed ID: 7798636
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Erythema migrans borreliosis in the Federal Republic of Germany. Epidemiology and clinical aspects].
    Schmidt R; Kabatzki J; Hartung S; Ackermann R
    Dtsch Med Wochenschr; 1985 Nov; 110(47):1803-7. PubMed ID: 3905325
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Localized scleroderma (morphea) and septic arthritis. Clinical manifestations of Lyme borreliosis seen in El Ferrol].
    Maestre JR; Almagro M; Martínez P; de Casas R; Quesada R; Egido J
    Enferm Infecc Microbiol Clin; 1991; 9(7):394-8. PubMed ID: 1799607
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Lyme borreliosis. Cutaneous manifestation].
    Hofmann H
    Hautarzt; 2005 Aug; 56(8):783-95; quiz 796. PubMed ID: 16025277
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Diagnosis of Lyme disease based on dermatologic manifestations.
    Malane MS; Grant-Kels JM; Feder HM; Luger SW
    Ann Intern Med; 1991 Mar; 114(6):490-8. PubMed ID: 1994797
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Cutaneous forms of Lyme borreliosis in children].
    Hercogová J; Fadrhoncová A; Jirous J
    Cesk Pediatr; 1990 Apr; 45(4):203-8. PubMed ID: 2249272
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.